The majority of individuals who have DS develop early onset-AD in mid-life [43], thus we could not source adult post-mortem brain tissue from individuals who had DS but who did not have AD, to determine if the level of cathepsin activity in absence of AD neuropathology differs between people with DS with and disomic individuals in the brain. This evidence concerns the gene CTSS and Alzheimer disease.